JFNCX
Janus Henderson Global Life Sciences Fund Class C [JFNCX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
JFNCX Stock Summary
Top 10 Correlated ETFs
JFNCX
Top 10 Correlated Stocks
JFNCX
In the News
JFNCX Financial details
Company Rating
-
Market Cap
5.28B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-1.96%
SMA50
-2.63%
SMA100
-2.09%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
53.35-64.47
52W High
+2.55%
52W Low
+23.83%
RSI
49.85
Rel Volume
-
Avg Volume
-
Volume
Perf Week
1.05%
Perf Month
0.92%
Perf Quarter
-5.58%
Perf Half Y
-3.91%
-
-
-
-
Beta
0.73
-
-
Volatility
0.56%, 0.87%
Prev Close
0.78%
Price
65.63
Change
0.78%
Company Profile
- Market Capitalization 5.28B
- Headquarters US
- IPO Date 2009-07-06
The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
